Final answer:
The treatment for active tuberculosis infection involves the use of multidrug protocols, including medications such as isoniazid, rifampin, ethambutol, and pyrazinamide. These treatments can last for months or even years. However, nonadherence to the prescribed treatment can lead to antibiotic resistance. Isoniazid, commonly used in TB treatment, may have adverse drug reactions such as hepatotoxicity, neurotoxicity, and hematologic toxicity.
Step-by-step explanation:
The treatment for active infection of tuberculosis involves the use of multidrug protocols. The commonly used antibiotics in these treatments are isoniazid, rifampin, ethambutol, and pyrazinamide. These medications need to be taken for months or even years due to the chronic nature of TB. However, nonadherence to the prescribed treatment can lead to antibiotic resistance, making the infection more difficult to control.
Some associated adverse drug reactions (ADRs) of isoniazid, which is commonly used in TB treatment, include hepatotoxicity (liver damage), neurotoxicity (damage to the nervous system), and hematologic toxicity (anemia).